Abstract #522: Calcitirol Mediated Hypercalcemia in A Patient with Silicone Granulomas dueto Cosmetic Injections: Clinical Case

2015 ◽  
Vol 21 ◽  
pp. 108-109
Author(s):  
Ana Abaroa-Salvatierra ◽  
Arti Patel ◽  
Mrunalini Deshmukh
Keyword(s):  
1995 ◽  
Vol 22 ◽  
pp. 29-35
Author(s):  
Jennifer Gutierrez ◽  
Anthony Caruso

2003 ◽  
Vol 19 (3) ◽  
pp. 164-174 ◽  
Author(s):  
Stephen N. Haynes ◽  
Andrew E. Williams

Summary: We review the rationale for behavioral clinical case formulations and emphasize the role of the functional analysis in the design of individualized treatments. Standardized treatments may not be optimally effective for clients who have multiple behavior problems. These problems can affect each other in complex ways and each behavior problem can be influenced by multiple, interacting causal variables. The mechanisms of action of standardized treatments may not always address the most important causal variables for a client's behavior problems. The functional analysis integrates judgments about the client's behavior problems, important causal variables, and functional relations among variables. The functional analysis aids treatment decisions by helping the clinician estimate the relative magnitude of effect of each causal variable on the client's behavior problems, so that the most effective treatments can be selected. The parameters of, and issues associated with, a functional analysis and Functional Analytic Clinical Case Models (FACCM) are illustrated with a clinical case. The task of selecting the best treatment for a client is complicated because treatments differ in their level of specificity and have unequally weighted mechanisms of action. Further, a treatment's mechanism of action is often unknown.


1995 ◽  
Author(s):  
George E. Abbott ◽  
◽  
Ray William London ◽  
Irving Kirsch

2014 ◽  
Vol 75 (S 01) ◽  
Author(s):  
Amancio Guerrero Maldonado ◽  
Sirajeddin Belkhair ◽  
Michael Tymianski ◽  
Ivan Radovanovic

2014 ◽  
Vol 45 (S 01) ◽  
Author(s):  
L. Voges ◽  
G. Stettner ◽  
D. Weise ◽  
K. Brockmann ◽  
J. Gärtner ◽  
...  

1983 ◽  
Vol 22 (03) ◽  
pp. 135-148 ◽  
Author(s):  
T. Kitaguchi ◽  
T. Nojiri ◽  
S. Suzuki ◽  
T. Fukita ◽  
T. Kawana

In order to meet the multifarious needs for drug information and to cope with the post-marketing surveillance of drugs adequately, an on-line drug information network, which is composed of two data bases, clinical case record data base and literature data base, has been developed. Primary considerations in designing these systems were input of clean data, accurate input, insuring that no ADRs are overlooked, accumulation of the latest data, saving manpower required for processing, and processing large quantities of data. This system is also designed to input and to output in Japanese character.


Sign in / Sign up

Export Citation Format

Share Document